A carregar...

Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II study

Epigenetic therapeutics such as the histone deacetylase inhibitor, vorinostat, and the DNA methyltransferase I inhibitor, azacitidine, enhance gemtuzumab ozogamicin efficacy in vitro. We therefore investigated vorinostat/azacitidine/gemtuzumab ozogamicin in 52 adults aged 50 years or over with acute...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Walter, Roland B., Medeiros, Bruno C., Gardner, Kelda M., Orlowski, Kaysey F., Gallegos, Leonel, Scott, Bart L., Hendrie, Paul C., Estey, Elihu H.
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4007917/
https://ncbi.nlm.nih.gov/pubmed/24142996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.096545
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!